NASDAQ · FRNM
Freenome, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for FRNM: Nov 10, 2026
Freenome, Inc. Common stock is expected to report earnings on 11/10/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. The reported EPS for the same quarter last year was $0.01.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · RTTNews- The Motley Fool · Oct 20, 12:50 PM EDTCathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtCathie Wood's Ark Invest bought shares of CoreWeave, Scribe Therapeutics, and Freenome on Monday.
- RTTNews · Oct 12, 3:17 AM EDTFreenome Highlights Improved SimpleScreen CRC Performance Data At ACG 2026; Stock Up(RTTNews) – Freenome, Inc. (FRNM), a company that develops blood tests for early cancer detection, announced it will present late-breaking data on an updated version of its SimpleScreen CRC blood-based screening test at the American College of Gastroenterology (ACG) 2026 Annual M
- RTTNews · Oct 12, 12:52 AM EDTFreenome To Present Improved Precancerous Lesion Detection Data For CRC Blood Test(RTTNews) – On Sunday, Freenome, Inc. (FRNM) said it will present new clinical validation data for an updated version of its SimpleScreen colorectal cancer (CRC) blood-based screening test at the American College of Gastroenterology (ACG) 2026 Annual Meeting in Nashville.
- RTTNews · Sep 21, 9:35 AM EDTBiotech Stocks At 52-Week Highs – HSCS +7%, FRNM +5%, VOGX, HTFL, HALO(RTTNews) – The following biotech stocks reached a 52-week high on September 18, 2026, driven by the gain on certain clinical trial results or an announced public offering.
- RTTNews · Sep 3, 4:08 AM EDTBiotech Stocks At 52-Week Highs – OABI +13%, FRNM, EXEL, FTH, LFST(RTTNews) – The following biotech stocks reached a 52-week high on September 2, 2026, driven by achieving new regulatory milestones or positive financial results.
- RTTNews · Aug 12, 1:05 PM EDTFreenome's SimpleScreen Lung Receives FDA Breakthrough Device Designation(RTTNews) – Freenome, Inc. (FRNM), an early cancer detection company developing blood-based screening tests, announced that the U.S. FDA granted Breakthrough Device Designation to its investigational SimpleScreen Lung test for early lung cancer screening.
- RTTNews · Jul 27, 10:43 AM EDTFreenome, Abbott Win FDA Nod For SimpleScreen CRC As Screening Test In Colorectal Cancer(RTTNews) – Freenome, Inc. (FRNM), an early cancer detection company, and Abbott Laboratories (ABT) announced Monday that U.S. FDA has approved SimpleScreen CRC, a blood-based screening option for patients with Colorectal Cancer aged 45 and older who are at average risk for the d
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Freenome, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.